Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.39 |
| ▸ | EGFR | P00533 | 4/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.36 |
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134193 | 0.83 | MEN1 (0.34) | MEN1KMT2AP2RX7MMP2MMP14 | |
| SCHEMBL29268539 | 0.83 | KMT2A (0.42) | MEN1KMT2APTGS2P2RX7EGFR | |
| SCHEMBL729640 | 0.79 | L3MBTL1 (0.50) | MEN1KMT2APTGS2PTGS1MMP2 | |
| SCHEMBL10571569 | 0.78 | KDM4E (0.39) | MEN1KMT2APTGS2EGFRLMNA | |
| SCHEMBL12000995 | 0.75 | CA1 (0.44) | MEN1KMT2APTGS2EGFRMMP2 | |
| SCHEMBL7456332 | 0.73 | ALDH1A1 (0.39) | MEN1KMT2AP2RX7EGFR | |
| SCHEMBL29268541 | 0.72 | PTGS2 (0.36) | PTGS2P2RX7EGFRPTGS1PKM | |
| SCHEMBL14645410 | 0.71 | GAA (0.45) | HDAC6 | |
| SCHEMBL914628 | 0.71 | CSNK1A1 (0.35) | MEN1KMT2AMMP2MMP14 | |
| SCHEMBL7081766 | 0.71 | NLRP3 (0.50) | MEN1KMT2ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024110852-A1 | A HERBICIDAL COMPOSITION AND A PROCESS FOR PREPARING THE SAME THEREOF | UPL LIMITED (IN) | 2024-05-30 | — | — | WO | claimed |
| US-20220151229-A1 | Synergistic Herbicidal Combinations | CLARIANT INTERNATIONAL LTD. (CH) | 2022-05-19 | — | — | US | claimed |
| EP-3930466-A1 | SYNERGISTIC HERBICIDAL COMBINATIONS | Clariant International Ltd (CH) | 2022-01-05 | — | — | EP | claimed |
| US-20210163451-A1 | METHODS AND COMPOSITIONS FOR SUBSTITUTED 2,5-DIKETOPIPERAZINE ANALOGS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2021-06-03 | — | — | US | claimed |
| US-20190116786-A1 | CONTROLLED RELEASE FORMULATIONS OF HERBICIDES | HICAP FORMULATIONS LTD (GB) | 2019-04-25 | — | — | US | claimed |
| US-20170118931-A1 | PREVENTION OF ROOT INTRUSION IN SUB-SURFACE STRUCTURES | IRRIGATION & WATER TECHNOLOGIES IP PTY LTD (AU) | 2017-05-04 | — | — | US | claimed |
| US-20160326540-A1 | Methods and Compositions Employing a Sulfonylurea-Dependent Stabilization Domain | PIONEER HI-BRED INTERNATIONAL, INC. | 2016-11-10 | — | — | US | claimed |
| US-20160262379-A1 | CONTROLLED RELEASE FORMULATIONS OF HERBICIDES | HICAP FORMULATIONS LTD (GB) | 2016-09-15 | — | — | US | claimed |
| CN-105473721-A | Methods and compositions employing a sulfonylurea-dependent stabilization domain | PIONEER HI BRED INT | 2016-04-06 | — | — | CN | claimed |
| CN-105473722-A | Methods and compositions to improve the spread of chemical signals in plants | PIONEER HI BRED INT | 2016-04-06 | — | — | CN | claimed |
| WO-2010022251-A2 | GABA/PESTICIDAL COMBINATIONS | PLANT HEALTH CARE, INC. (US) | 2010-02-25 | — | — | WO | claimed |
| US-20100048397-A1 | GABA/Pesticidal Combinations | PLANT HEALTH CARE, INC. | 2010-02-25 | — | — | US | claimed |
| US-20080254983-A1 | Herbicide Composition | NUFARM AUSTRALIA LIMITED (AU) | 2008-10-16 | — | — | US | claimed |
| EP-1933621-A1 | HERBICIDE COMPOSITION | NUFARM AUSTRALIA LIMITED (AU) | 2008-06-25 | — | — | EP | claimed |
| WO-2007030887-A1 | HERBICIDE COMPOSITION | NUFARM AUSTRALIA LIMITED (AU) | 2007-03-22 | — | — | WO | claimed |
| US-20060183638-A1 | Safer control of broadleaf weeds in turf with granular formulations of ALS inhibiting herbicides | CORTEVA AGRISCIENCE LLC | 2006-08-17 | — | — | US | claimed |
| WO-2006081441-A1 | WASTE TREATMENT BY IN-CONTAINER VITRIFICATION | GEOSAFE CORPORATION (US) | 2006-08-03 | — | — | WO | claimed |
| WO-2006016882-A2 | METHODS AND MATERIALS FOR ENHANCING THE EFFECTS OF PROTEIN MODULATORS | NDSU RESEARCH FOUNDATION (US) | 2006-02-16 | — | — | WO | claimed |
| US-20060009918-A1 | Methods and materials for enhancing the effects of protein modulators | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2006-01-12 | — | — | US | claimed |
| US-4944792-A | HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1990-07-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220151229-A1 | Synergistic Herbicidal Combinations | GRM1, FFAR1, GRM2 | MEN1 1299/4885KMT2A 985/4885PTGS2 1537/4885 |
| US-20080254983-A1 | Herbicide Composition | DDT, HDHD5, CUL5 | MEN1 4300/4885KMT2A 1394/4885PTGS2 2466/4885 |
| US-20210163451-A1 | METHODS AND COMPOSITIONS FOR SUBSTITUTED 2,5-DIKETOPIPERAZINE ANALOGS | TKT, HAAO, TALDO1 | MEN1 3193/4885KMT2A 1039/4885PTGS2 2497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.